"The CRO made a mistake so now there’s a 16% decrease from placebo."
That's not what happened at all. Read it again. There was a 16% relative reduction in the incidence of SOM in the avasopasem treatment group (54%) vs. placebo group (64%) before AND after the correction of the p-values.
56% relative reduction in the number of days of SOM in the avasopasem treatment group (8 days) vs. placebo group (18 days) (p=0.0022*) (previously reported as p=0.011) (secondary endpoint)